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Abstract
Objective: Evaluate best practice in managing anxiety in the pediatric population, including
both school age children and adolescents. This literature review compared pharmacological
treatment and cognitive behavioral therapy (CBT)’s effectiveness on the management of
anxiety within the pediatric population. Background: Up to 25% of children in the United States
are affected by a mental health disorder, anxiety being the most prevalent. Childhood anxiety
can have a distressing impact on social, family, and academic functioning. If persisting into
adulthood it increases the risk of developing other co-occurring mental health conditions,
substance abuse issues, and contributes to impaired employment retention and socioeconomic
burden. Addressing anxiety early has shown to have a lasting positive effect that carries
forward into adulthood. Method: Five databases were selected to yield the highest levels of
evidence. Key words from the clinical question were searched which generated the most
prevalent hits. Sixty-five studies were identified, 16 were duplicates. Of the 49 studies
reviewed, 22 met the inclusion criteria. A literature review of the 22 studies was conducted and
synthesized. Results: The combination of CBT and pharmacotherapy are far superior for
pediatric anxiety than either treatment alone. Individually, CBT is more effective than
pharmacotherapy with a longer lasting benefit and should be offered to all children with
anxiety. Children with severe anxiety should utilize both CBT and pharmacotherapy as together
they improve the likelihood of response and remission.
Keywords: pediatrics, paediatrics, children, child, adolescents, youth, best practice,
evidence based, assessment, screening, treatment, anxiety, anxiety disorder, mindfulness, CBT,
cognitive behavioral therapy, outcome, non-pharmacological interventions, pharmacological
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Childhood Anxiety: Cognitive Behavioral Therapy and/or Pharmacological Treatment
The transition through childhood and into adulthood could be argued as one of the
most vulnerable life experiences. Many healthcare providers now acknowledge the impact
childhood experiences have on adulthood and realize the importance of facilitating this
transition. After all, children are the future. Transitions of childhood have been well studied,
developmental and functional stages well defined. There is a growing body of literature
evaluating how childhood exposures impact lifelong outcomes and health in adulthood.
Healthcare providers now know long-term eating behaviors are learned as a toddler; thus, it is
critical to establish good eating habits at this age otherwise poor habits may lead to lifelong
ramifications (Burns et al., 2017). Spanking is taught to have no place in the area of discipline
due to the knowledge that children who receive spanking or physical force as a form of
discipline are at much higher risk of developing physical force as a means to express anger and
deal with conflict (Richardson, 2020). Providers also now have a greater understanding
regarding the significance of adverse childhood events (ACEs). There are long-term associations
between ACEs and adulthood health risks behaviors, health status, disease, and death (Felitti et
al., 1998). Early adversity has a long-lasting impact as an adult and has the potential to
influence many domains including injury, mental health, maternal health, infectious disease,
chronic disease, risk behaviors, and life opportunities (Centers for Disease Control and
Prevention [CDC], 2019). These examples emphasize that much of what occurs during
childhood translates to who these individuals become as adults. One common co-occurrence in
childhood and adulthood is the prevalence of anxiety. Adult psychosocial disorders can often be
linked to childhood anxiety that persisted into adulthood. Childhood anxiety has been found to
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predispose individuals to various health conditions and negatively impact functioning, making it
an important consideration when caring for children and adolescents.
Many factors contribute to the risk and onset of anxiety in childhood. There are,
likewise, many issues childhood anxiety predisposes someone to developing as an adult. There
are, however, effective ways of managing childhood anxiety to minimize the life lasting effect it
may have. The treatment of childhood anxiety should be a shared decision between providers,
patients, and parents. Everyone involved in decision-making should be well informed about the
options available as well as their effectiveness and long-term outcomes on the diagnosis of
anxiety.
Background
Common childhood anxiety disorders include social anxiety, generalized anxiety,
obsessive-compulsive disorder (OCD), and separation anxiety (Burns et al., 2017). Roughly 2025% of children in the United States are affected by mental health or psychosocial problems
(Burns et al, 2017; Wehry et al., 2015). Among mental health problems, anxiety is easily the
most prevalent diagnosis (Adler Nevo et al., 2014; Crawford et al., 2013). More recent literature
suggests a growing prevalence of childhood anxiety, reaching as high as 32% in the United
States (Ege & Reinholdt-Dunne, 2016). It should be emphasized that although anxiety in
childhood is labeled as a common condition, this does not translate as normal. There is a
distinction to be made between the symptoms of anxiety, normally experienced by everyone at
some point in their lives, and a persistent maladaptive behavior that classifies a diagnosis of
anxiety. A formal anxiety diagnosis is not a normal developmental experience.
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Misunderstanding this difference between normal anxiety symptoms and abnormal anxiety
manifestation contributes to the underdiagnosing of childhood anxiety. It is disappointing that
only 22% of adolescents who meet diagnostic criteria are diagnosed and treated by their
primary care provider (Burns et al., 2017). This emphasizes a need for improvement in
recognizing and managing anxiety.
Nonetheless, it is relatively easy to understand how children fly under the radar of being
diagnosed. Anxiety is often an internal process that may not be an obvious problem to those
around the child, including parents, let alone a provider who sees them far less often (Boorady,
2020). Children with anxiety may portray symptoms in a wide variety of ways. Often, they are
labeled as inattentive or easily distracted. They may be fidgety or have behavioral outbursts.
Sleep is a necessity for brain development and function (Burns et al., 2017), anxiety however,
disrupts sleep and is known to contribute to sleep disorders. The disruption it causes in sleep
may in part contribute to how anxiety is manifested clinically by the child. At the very least, the
disturbance of sleep negatively impacts their anxiety symptoms. Additionally, children with
anxiety commonly have a host of physical problems or complaints such as headaches, and
stomachaches (Boorady, 2020). Though one exact cause of anxiety is unknown, it is likely
multifactorial. The phrase ‘the apple doesn’t fall far from the tree’ is often referenced when
comparing children to their parents. It is notable that children learn from their parents and
children of anxious parents are at a much higher risk of developing an anxiety disorder
themselves (Cartwright-Hatton et al., 2018). Anxiety may likely occur due to risk factors
including genetics, a temperamental disposition such as shyness, social and/or environmental
exposures, or life circumstances (Burns et al., 2017).
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Untreated childhood anxiety can be very disabling and lead to chronic anxiety in
adulthood. Childhood anxiety is known to negatively impact social and family functioning
(Crawford et al., 2013). It additionally is the leading reason for school refusal, thus negatively
impacting academics (Burns et al., 2017). Separation anxiety is a risk factor for panic attacks
and disorders which can be very debilitating (Burns et al., 2017). Sustained anxiety into
adulthood is concerning as it predisposes an individual to developing diverse psychiatric mood
disorders and substance abuse disorders or dependence (Crawford et al., 2013). It is significant
that approximately 32% of children with anxiety will carry this diagnosis forward with them into
their adult years, making them susceptible to these co-occurring conditions (Burns & Thiessen,
2014). Furthermore, sustained anxiety in adulthood is responsible for poor employment
retention and outcomes (Adler Nevo et al., 2014). Anxiety not only causes individual distress
and life-altering challenges, but it becomes an economic burden to society as well (Adler Nevo
et al., 2014). Given anxiety disorders are among the most prevalent conditions affecting
children and the distress it can cause on an individual and society, accurately diagnosing and
treating anxiety should hold high importance in the minds of providers. Most cases of childhood
anxiety are diagnosed before 12 years of age (Burns et al., 2017), 50% of cases occurring by six
years of age (Ege & Reinholdt-Dunne, 2016). This early onset emphasizes the necessity for early
screening and intervention to minimize risk of untreated or long-term effects of anxiety.
Treatment of anxiety may include pharmacological therapies including selective serotonin
reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), and tricyclic
antidepressants (TCAs). An underappreciated, yet effective, treatment includes CBT.

7
Of the treatment approaches available, CBT and SSRIs are viewed as the first line
treatment options for childhood anxiety (De Souza et al., 2013). CBT has been one of the most
extensively studied forms of psychotherapy (Butler et al., 2006). Regardless of it being proven
to be an effective alternative modality in anxiety management, it remains underutilized
compared to pharmacological interventions. CBT works by targeting and modifying cognitive
dysfunction through psychotherapy using cognitive and behavioral techniques (Ege &
Reinholdt-Dunne, 2016). It has been found to be effective in the management of several
psychiatric disorders and has a lasting effect beyond the cessation of treatment (Butler et al.,
2006). CBT is most commonly administered through in-person therapy guided sessions. There
are growing opportunities for CBT to be administered in a variety of settings including therapist
guided parent-delivered sessions, school based, and computer or internet delivered. CBT is
often delivered over a course of several weeks and is viewed as short-term therapy. Therapy
sessions may range from 5-20 sessions depending on an individual’s need (Mayo, n.d.). Cost of
CBT is often an initial concern. Although the cost of CBT varies, it has been found to be
significantly lower than treatment as usual with pharmacotherapy (Dickerson et al., 2018).
The goal of this literature review was to evaluate the best approach to managing
childhood anxiety, specifically looking at pharmacological treatment verses CBT and if one
modality is superior to the other or if a combined approach is most efficacious. The clinical
question is: in school aged children (5-12 years old) and adolescents (12-18 years old) how does
the efficacy of CBT compare to pharmacological treatments in the management of anxiety? This
literature review also looked to answer an additional clinical question, including: What is the
most effective tool in screening for childhood anxiety? Recurring themes found in the literature
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were also reviewed in the synthesis. The results of this literature review are intended to inform
providers of the best management approach for childhood anxiety and how to best carry out
the recommended treatment. It is clinically significant to adequately treat childhood anxiety
considering the prevalence of which anxiety is seen and therein reduce the risk untreated
anxiety poses to this population as adults. More attention needs to be drawn to mental health
in general, but particularly in the childhood population if providers are to make a lasting
difference for the future.
Methods
In descending order, the best levels of evidence to evaluate an intervention question
include systemic review/meta-analysis, randomized controlled trials (RCTs), non-RCTs, cohort
studies or case-control studies, meta-syntheses of qualitative or descriptive studies, qualitative
or descriptive single studies, and expert opinion (Melnyk & Fineout-Overholt, 2015). The
databases identified for this literature review were aimed at collecting the highest level of
evidence. Then, a broad database abstraction was done evaluating the hit results of the key
terms derived from the PICO question. Based on the hit results, a literature review was
conducted to screen for inclusion and exclusion criteria prior to synthesizing data.
Databases
The databases searched included Cochrane, CENTRAL, MEDLINE, CINAHL, and PsycINFO.
Cochrane Database of Systemic Reviews is the gold standard database and should be among
the first searched for intervention questions (Melnyk & Fineout-Overholt, 2015). Cochrane is
where systemic reviews can be found in answering intervention questions. This is a smaller
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database given it contains systemic reviews which are fewer and farther between. Another
database that was searched included the CENTRAL database, which serves as the most
comprehensive source of controlled trials. MEDLINE was a utilized database because it is the
largest searchable database covering medicine and health. CINAHL database was used as it
contains many subject areas, one being alternative/complimentary medicine which was an
important component of the clinical question. Lastly, PsycINFO was another database explored
given the mental health aspect of the clinical question. Refer to Table 1 in the appendix to
visualize the databases used along with the corresponding restrictors, expanders, dates, and
general subjects covered in the literature search.
Search Strategy
Each database was searched using the following key words, which were variations of the
original clinical question, including; pediatrics, paediatrics, children, child, adolescents, youth,
best practice, evidence based, assessment, screening, treatment, anxiety, anxiety disorder,
mindfulness, CBT, cognitive behavioral therapy, outcome, non-pharmacological interventions,
pharmacological. After the initial key word search, a correlating search strategy was applied.
This strategy included a cross search, looking at the variations of the key terms and cross
searching those results with each aspect of the PICO question. Lastly, a bibliography review was
done on the studies that passed inclusion criteria. This process can be visualized in Table 2 of
the appendix which shows the key words searched and the number of hits for the
corresponding databases. Table 2 also demonstrates in bold the groups of articles reviewed for
inclusion or exclusion.
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Studies that evaluated CBT for anxiety as well as pharmacological treatment for anxiety
were included in this review. Inclusion criteria was also dependent on age, including
neurotypical pediatrics between 5-18 years old. Studies pertaining to early childhood or adults
outside the stated pediatric range of interest were excluded. Studies evaluating the therapies
for conditions other than anxiety or studies evaluating these therapies for anxiety in the setting
of another disorder, i.e., autism, PTSD, were excluded. This literature review looked to evaluate
the effectiveness of CBT in comparison to pharmacological management of anxiety in the
neurotypical pediatric population without other confounding factors. The exclusion criteria
focused this review to yield the best results of treatment for anxiety disorders in pediatrics. In
total, 65 studies were identified, 16 were duplicates, leaving 49 articles. Of the 49 articles that
were reviewed, 22 met the inclusion criteria. Refer to Table 3 in the appendix for the studies
included or excluded along with the rationale.
The literature review process was conducted on all the included articles based on the
method and inclusion/exclusion criteria. Table 4 summarizes the key aspects of the literature
that were included and reviewed. Table 4 was developed prior the synthesis of data as a means
data abstraction and organization.
Methodological Strength
This literature review yielded quality evidence for the intervention question. Using the
Hierarchy of Evidence (Melnyk & Fineout-Overholt, 2015), sixteen of the 22 articles (72%) were
Level III evidence or higher, with the majority being Level II with RCTs accounting for 10 articles.
One article met Level I evidence criteria as a systematic review. The second major grouping
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being Level III which included five articles. The remaining five articles were Level IV evidence or
lower.
Literature Review
Study Characteristics
All studies evaluated the pediatric population, and the majority of studies evaluated
both school-age children and adolescents between 7-18 years of age. The youngest age
included in any of the studies was five years. Four studies looked specifically at school-age
children (5-12 years). Four separate studies specifically looked at adolescents (10-17 years). The
studies differed in the types of anxiety that were included, and this is acceptable due to the
knowledge that often different anxiety types co-occur. The anxiety types found in the literature
included various combinations of generalized anxiety, social anxiety, social phobia, and
separation anxiety.
As for the interventions, CBT and pharmacological treatment were the focus of interest.
The studies evaluating CBT administered between 12-18, 60-minute sessions of CBT. The
majority of studies developed their CBT protocol from The Coping Cat program. The original
Coping Cat program involved 14 sessions over 12 weeks. Two were parent only and the
remainder child sessions. The sessions included developing skills and training in anxiety
management. This was followed by practice with anxiety provoking situations that were
tailored to the participants needs and anxieties (Gonzalez et al., 2015). For those studies that
evaluated pharmacotherapy, they almost exclusively utilized sertraline and had eight sessions
for medication management and systematic adjustment in dosing. The tools most utilized by
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the studies to obtain baseline assessment and post treatment outcomes were the Pediatric
Anxiety Rating Scale (PARS) and the Screen for Child Anxiety Related Disorders (SCARED)
anxiety screeners. PARS was used more than SCARED, seven studies to four respectively.
CBT vs Pharmacotherapy Research Synthesis
CBT and SSRIs are known as the first line treatment options in the management of
childhood anxiety. Within recent years research has expanded, evaluating their effectiveness,
trying to identify the superior treatment options, and long-term outcomes. Although there is no
agreement on which individual treatment (CBT or SSRI) is more effective, the consensus of the
literature is that CBT and pharmacotherapy together are far superior than either alone (Beidas
et al., 2014; Burns & Thiessen, 2014; Walkup et al., 2008). Together, CBT and sertraline have
response rates of 80% or higher (Beidas et al., 2014; Walkup et al., 2008). Given the high
likelihood for success, it could be argued that combination therapy should be offered to all
youth with anxiety disorders. The treatment approach could, however, be broken down based
on the severity of the child’s anxiety. For children presenting with mild anxiety, all three
therapies (combination or either CBT or SSRIs alone) are reasonable, producing favorable
outcomes. Remission rates for combination therapy, sertraline alone, or CBT alone in mild
anxiety can reach as high as 80% (Beidas et al., 2014). Untreated anxiety that progresses to
moderate or severe anxiety decreases the responsiveness of therapy across the board. A 2014
study found that for severe anxiety the response and resolution of their anxiety diagnosis
varied between treatment groups, 62% responded to combination therapy, 49% responded to
CBT alone, and only 27% responded to sertraline alone (Beidas et al., 2014). Additionally, higher
levels of anxiety are associated with poorer long-term outcomes (Gibby, Casline, & Ginsburg,
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2017). The reduced response rate and potential for poorer long-term outcome highlights the
importance of early diagnosis and intervention to promote the best likelihood for success and
remission of anxiety. If a patient is presenting with severe anxiety, providers should encourage
combination therapy to increase the likelihood of response and improve outcomes (Beidas et
al., 2014). For milder presentations of anxiety, there is more leeway in the treatment choice.
Findings show that with mild anxiety there is generally more favorable outcomes with any
treatment, making all three options a reasonable starting point. This information can help
facilitate the shared decision-making process by presenting the likelihood for success of each
treatment option based on the severity of symptoms. These statistics further help to provide
clear, easily digestible, and realistic expectations for families. However, there are a few
exceptions to consider.
CBT and pharmacotherapy together are superior, but if this is not a desired or feasible
treatment approach then the literature suggests that CBT is superior to pharmacotherapy with
a few exceptions. Nearly all studies in this literature review either found CBT to be superior to
pharmacotherapy or at the very least equally effective. As mentioned above, for school-age
children and adolescents with severe anxiety, CBT was superior with a 49% response rate as
compared to pharmacological treatment with a 27% response rate (Beidas et al., 2014).
Another 2013 study evaluating CBT, medication, and combination therapy found similar results
with CBT being superior to medication. Alone CBT had a 63.6% response rate whereas
medication alone had a 50% response rate (Masi et al., 2013). More recent literature and a
Cochrane review also supported that CBT appears to be more effective than treatment as usual,
still there is a need for more research to definitively determine the superiority (James et al.,
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2018). The largest study to date evaluating pediatric anxiety involved 488 children and, not
surprisingly, found the combination of CBT and sertraline to be more effective than either
alone. The therapies alone had a response rate of 59.7% and 54% for CBT and sertraline
respectively. Although this large study did not show a statistically significant difference, those
receiving CBT had a lower dropout rate as well as less insomnia, fatigue, sedation, and
restlessness than the sertraline group (Walkup et al., 2008). Considering the sertraline group
had higher rates of side effects and dropouts, a limitation of this study was the potential for
skewed results. Regardless, even though comparable in effectiveness, if side effects are a
concern, CBT has proven to be an admirable alternative to pharmacological management. A
notable theme favoring CBT is seen when reviewing separate studies looking specifically at
these treatment options versus controls. CBT generally had higher rates of response, improved
remission rates, and more favorable outcomes. Trials of CBT versus controls found response
rates from 56%-95% (Chiu et al., 2013; De Souza et al., 2013; Galla et al., 2012) and remission
rates up to 83% (Galla et al., 2012) versus controls response rates of 16-28% (De Souza et al.,
2013; Galla et al., 2012). As for medication versus controls, medication response rates remain
around 50-55% in varying studies compared to a response rate around 24% in the control
groups (Burns & Thiessen, 2014; Wehry et al., 2015). While not compared head on, this
supports the suggestion that CBT has higher response and remission rates of anxiety,
demonstrating its superiority.
The exception of when CBT is not superior to pharmacotherapy is for children with a
family history of anxiety. A positive family history of anxiety has been associated with a six-fold
decrease in effectiveness of CBT compared to families without a family history of anxiety
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(Gonzalez et al., 2015). When CBT versus sertraline was evaluated in the setting of anxious
parents, the children receiving sertraline had more favorable responses (Gonzalez et al., 2015).
Anxiety often clusters in families (Burns et al., 2017), thus this would be one exception where
pharmacotherapy is the superior treatment choice. This knowledge allows for a more tailored
and individualized approach with consideration of the child’s genetics and environment. With
this being said, combination therapy remains superior, regardless of parental anxiety level
(Gonzalez et al., 2015).
Long-Term Outcomes
Another consideration in choosing a treatment approach is the long-term effect and
outcomes. Despite the fact that recent research indicates CBT is superior to pharmacotherapy,
providers ultimately care about the long-term effect and prevention of anxiety into adulthood.
The most recent research has been evaluating long-term outcomes and predictors of treatment
success for both these treatment options. The therapeutic effects of CBT appear to persist,
compared to pharmacological treatment, but evidence is limited (James et al., 2018). A longterm follow-up study, with an average follow up at 50 months post treatment, found a 79%
remission rate of those who received CBT versus no treatment (Brown et al., 2017). This
indicates treatment gains are maintained for several years even after treatment is
discontinued. It can be extrapolated that CBT may have a curative effect on childhood anxiety.
This can be appreciated given the goal of CBT is to modify behavior and provide lifelong skills
that may carry forward despite stopping treatment. A different study, with a six year follow up,
found sustained effect with remission of anxiety for all treatment groups, including sertraline,
CBT, and combination therapy (Wehry et al., 2015). Another study found that 76% no longer
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met diagnostic criteria of those who received either CBT or SSRI (Gibby et al., 2017). These two
studies highlight that, regardless of treatment, there appears to be sustained long-term benefit
if there is an initial treatment response. Only one long-term follow-up study of eight years had
contradictory outcomes indicating that regardless of treatment or no treatment, there was a
50% remission of anxiety diagnoses (Adler et al., 2014). These findings imply that there may be
some childhood anxieties that spontaneously remit. However, that perspective remains a
debate, and knowledge of who spontaneously remits is unknown.
Researchers are beginning to evaluate potential predictors of treatment remission.
Some factors, unfortunately, cannot always be predicted such as negative life events that have
not yet occurred. Though the Adler et al (2014) eight-year follow up study concluded that
childhood anxiety may improve without treatment, there may be bias. When collecting
participants, researchers had far more participants from the non-treatment group decline
participation at the eight-year follow up. This theoretically could have significantly skewed the
data if it was hypothesized that the ones in the non-treatment group who declined
participation were the ones who still carried an anxiety diagnosis. Adler et al. (2014) suggest
that not all childhood anxiety needs to be treated and not all childhood anxiety will proceed
into adulthood however there is no reliable means of deciphering which children are at risk.
Given healthcare providers do not have good predictors and cannot forecast life events, this
single study does not outweigh the potential benefit of treatment in light of the unknown
variables. It does however raise question to the many unknowns about the long-term course of
anxiety. Even though some believe anxiety may spontaneously remit, the general consensus is
that children do not simply just outgrow their anxiety. The course of anxiety is a waxing and
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waning process and is overall considered to be chronic and persistent, leading to psychiatric
disorders in adulthood if left untreated (Wehry et al., 2015).
Predictors of Treatment Success
Despite best efforts to individualize care, it can be challenging to identify which
treatment approach is best in each circumstance. Researchers continue to evaluate predictors
of treatment success and factors that contribute to successful treatment outcomes. One study
found that study participants with higher IQs have better responses to CBT (Benford, 2017).
Moreover, concurrent family dysfunction or parenting stress have been correlated with poorer
CBT response (Bunford, 2017). Children who are initial responders to treatment have been
shown to have better long-term outcomes as compared to initial non-responders (Gibby et al.,
2017). Positive parental and patient expectations that treatment will lead to better outcomes is
a robust predictor of adherence and positive outcomes (Zehgeer et al., 2018). Additionally,
those living with two parents is another positive predictor of treatment adherence that impacts
outcome (Zehgeer et al., 2018). Life events are another emerging predictor of outcomes, and
those experiencing a greater number of negative life events have poorer outcomes (Gibby et
al., 2017). Even still, life events may not be modifiable, so facilitating family coping strategies
during such times is important. Another factor contributing to outcomes is family
accommodations (FA). FA behaviors include talking on behalf of the child, letting them sleep in
their parents’ bed, providing special meals, facilitating and allowing school avoidance or
avoidance of other activities. FAs have been shown to negatively impact child anxiety by
maintaining anxiety as opposed to alleviating symptoms (Norman et al., 2015). Though
unknown to the parent, these FAs negatively reinforce reliance on parents and hinder
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independent growth and coping skills (Norman et al., 2015). Recognizing and educating parents
on how these problematic behaviors impact treatment response and outcomes is needed. To
date, of the longitudinal studies evaluating study subject’s post-treatment, none found that
age, race, gender, or ethnicity had a clear impact on the duration of outcomes (Gibby et al.,
2017).
These emerging predictors of treatment success can help guide treatment decisions
though are in early stages of analysis. The most meaningful predictor at this time is baseline
severity of anxiety predicting treatment response, as previously described (Beidas et al., 2014).
Those with severe anxiety have lower success rates and higher rates of continued anxiety,
which impact behaviors and psychological conditions in adulthood. This knowledge aids
predicting outcomes and is meaningful for making informed decisions regarding the best
treatment. It likewise allows for better communication and the ability to set reasonable
expectations for long-term prognosis with families. Again, this information highlights the need
to screen for early signs of anxiety and facilitate family functioning early on to achieve a more
favorable treatment response and patient outcome.
Recurring Themes of Literature to Aid Providers
Screening for Childhood Anxiety
Unfortunately, it is not uncommon for the diagnosis of anxiety to be given more than 20
years after symptom onset (James et al., 2018). Due diligence has not been achieved when it
comes to screening childhood anxiety. Anxiety starts early in development with the median age
of onset at six years old (Gibby et al., 2017) with social anxiety peaking in adolescents (James et
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al., 2018). Clinical presentation varies greatly, hindering accurate diagnosis. Children likely
present with somatic complaints of muscle tension, headaches, stomach aches, or anger
outbursts (James et al., 2018). Often, children are first presenting in the nurse’s office at school
with varying physical complaints (Burns & Thiessen, 2014). Other characteristics may include a
shy disposition, soft spoken, avoidance of eye contact, rigid posture, blushing, or activity/school
avoidance behaviors (Burns & Thiessen, 2014). It is important to remember that anxieties
cluster in families, thus providers should screen carefully in children of anxious parents
(Gonzalez et al., 2015). Children who present with any of these varying complaints should have
anxiety as a leading differential. If organic disease is ruled out, then anxiety should be more
thoroughly explored. Beyond symptom presentation, providers should be inquiring about
anxiety routinely as often families are hesitant to disclose anxiety early on due to stigma or
concern for judgement on their parenting style (Norman et al., 2015).
A majority of the literature utilized the PARS or SCARED screening tool. PARS is a useful
tool because it can benchmark treatment response. However, it is time intensive, it requires
training for administration, (McGuire et al., 2019) and requires clinician grading (Wehry et al.,
2015). Whereas SCARED can similarly be used for monitoring treatment response, it is a youthand parent-rated anxiety scale that requires minimal training and interpreting (McGuire et al.,
2019). SCARED is cost effective, as it is free and accessible online, and it has good reliability and
validity. SCARED is recommended by NICE guidelines (Burns & Thiessen, 2014) and has the
advantage of differentiating between different types of anxiety. In real world practice, SCARED
is the favored screening tool for childhood anxiety though PARS is what is frequently utilized in
trials (Wehry et al., 2015).
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Treated vs Untreated
It is important to accurately diagnose anxiety early, but it is equally as important to treat
it early. Early detection and intervention can prevent the development of abnormal behavioral
patterns that interfere with functioning and lead to comorbidities in adulthood (Burns &
Thiessen, 2014). Pediatrics who show positive response to initial treatment are far more likely
to be anxiety free and less impaired in the long-term. Additionally, responders are significantly
less likely to have depression and less likely to use marijuana or other substances (Gibby et al.,
2017). Children who were older when they first received treatment were more likely to need
interim mental health services, further emphasizing earlier intervention is better (Gibby et al.,
2017). Untreated anxiety is a gateway illness for other lifelong adult psychiatric mood disorders.
It is associated with higher rates of school dropout, and decreased quality of life, employment
opportunity, and socioeconomic status. Additionally, with retained anxiety individuals are more
likely to remain single and less likely to participate in life joys including social and leisure
activities (Burns & Thiessen, 2014). Those with retained anxiety are also more prone to have
children with anxiety given the tendency of clustering in families likely due to genetic and
environmental factors (Burns et al., 2017). This literature review has highlighted the importance
of treatment in light of all the potential negative outcomes that result from untreated anxiety.
Barriers to CBT
Though CBT is superior, it is significantly underutilized in real world practice, primarily
due to barriers. In fact, treatment for anxiety in general is significantly underutilized with only
17% of children with anxiety receiving treatment in the United States (Salloum et al., 2016).
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Barriers for CBT include lack of dissemination outside of specialty clinics and into community
settings, geographic barriers, shortages of therapist, cost, need for ongoing therapy, and time
consumption of therapy (Crawford et al., 2013; Salloum et al., 2016). Additionally,
recommending CBT has proven to be a challenging barrier for providers on multiple levels due
to lack of training, limited availability, large provider caseloads, and the varying clinical
presentations impacting diagnosis (Crawford, et al., 2013). The common barrier from a parents’
perspective are that they either do not recognize their child’s problem as serious, they want to
resolve the problem on their own, their worry about others knowing about treatment, or they
simply don’t not know where to go (Salloum et al., 2016).
Methods of CBT
Historically, CBT has been done through in-person therapy sessions. More recently,
smaller studies have evaluated the effectiveness of other treatment modalities for CBT. The
good news is that CBT appears to be equally effective in various formats including family,
individual, group, and online as well as across a variety of other settings (James et al., 2018).
This has huge implications for management of childhood anxiety in addressing the many
barriers to receiving in-person CBT. Receiving face-to-face therapist delivered CBT has been a
challenge on many fronts including scheduling conflicts, availability, accessibility,
transportation, and more. This is disappointing given how effective CBT is for childhood anxiety.
Fortunately, recent studies have looked at delivering CBT in various formats and settings in
attempt to expand its availability and minimize barriers to receiving this treatment with their
effectiveness looking promising.
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A study from 2017 looked at computerized CBT and guided parent-delivered CBT and
found these approaches are effective and have comparable outcomes to in-person therapy
(Brown et al.). One study with therapist-guided internet delivered CBT with supplemented
group and parent sessions had a 47% remission rate post treatment and 57% remission rate at
6 months post treatment (Nordh et al., 2017). These findings demonstrated the continued
benefit and effectiveness over time. Another study found computer-assisted CBT had an 86.7%
remission rate and that parents and children were highly satisfied with the treatment approach
(Crawford et al., 2013). Computer- and parent-guided CBT have the significant advantages of
being flexible and easily incorporated into daily life at home. Another logical place for CBT is
within schools. School settings of CBT have shown significant response. One study had an initial
response rate of 95.5% and a 1-year remission rate of 83% while controls only had a response
rate of 16.7% while on waitlist (Chiu et al., 2013; Galla et al., 2012). Beyond addressing some of
the initial barriers to receiving CBT, there have been other added benefits. For instance,
computer-delivered CBT has allowed for more individualized scenarios to be played out. This
modality can expose the child to specific anxiety scenarios and allow them to play it out and
practice behavior modification in a controlled setting (Burns & Thiessen, 2014). The
effectiveness of these varying modalities and settings allows for more opportunity for the child
and parent to receive CBT.
Gaps in Literature
Several gaps in the research literature for childhood anxiety exist. To start, there is very
little known about the natural course of anxiety. Debate exists between how much, if any,
childhood anxiety spontaneously remits. There is varying literature on the different types of
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childhood anxiety. Each study focused on varying combinations of the different types of anxiety
including social, generalized, and separational anxiety as well as, OCD. It remains a possibility
that each type of anxiety may have different long-term implications. However, it is difficult to
isolate anxiety types due to the common co-occurrence they have with each other. Childhood
anxiety is a known risk for varying conditions in adulthood, though predictors of which children
will experience remission, and which will go on to develop adulthood conditions are in the early
defining stages. CBT has been proven to be an effective and superior treatment option with
long lasting benefit. However, tackling barriers to receiving this treatment remains a gap in
knowledge. Most recently, literature has explored different avenues of CBT settings and though
results are promising, they are still in the early stages. These gaps in the research literature
cloud providers interpretation and generalization of results into practice, highlighting the
continued need for more research in this field.
Discussion
Childhood anxiety is common among the pediatric population and is associated with
lifelong implications. An anxiety diagnosis in childhood risks the wellbeing of the patient’s acute
health as well as their adult health. Adequate screening, diagnosing and treating childhood
anxiety is in the best interest of not only the child but their family and society as well. Children
are the future, addressing anxiety early has shown to have a lasting positive effect that carries
forward into adulthood. The treatment of anxiety is very personal and should be individualized
to incorporate the best evidence.
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CBT and pharmacotherapy together are far superior in treating pediatric anxiety than
either treatment alone. When these two treatments are compared alone, CBT is more effective
than pharmacotherapy, with only a few exceptions. Additionally, CBT also has a longer lasting
benefit that should be further explored in future research. Pharmacotherapy remains a
respectable first line treatment option, but it is not the superior method and thus should not
continue to be utilized as such in practice. Rather, CBT and pharmacotherapy should be offered
to all children with anxiety as first line treatment. Shared decision-making should be utilized
when choosing the treatment regimen. Education on the expected response rates for the
combination of CBT and pharmacotherapy as well as both options alone should be provided to
families. This information will facilitate families in making informed decisions given their
specific circumstances.
The most meaningful information to guide treatment decisions is the severity of the
child’s anxiety at the time of presentation. Pediatrics with severely rated anxiety should be
strongly encouraged to receive a combination of CBT and pharmacotherapy. Together they
improve the likelihood of response and remission for patients with severe anxiety, as neither
CBT nor medication alone are as effective (62%, 49%, 27% response effectiveness respectively).
Those with mild to moderately rated anxiety should still be offered the combination of
treatments given its superiority, but there are more favorable and comparable outcomes for all
three treatment options with non-severe anxiety. When combination therapy is not desired, if
there is a strong family preference, family dysfunction, low patient IQ, or the patient has
anxious parents, then pharmacotherapy should be offered. These are the only circumstances
when pharmacotherapy has been shown to be superior to CBT. For everyone else, CBT is the
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superior treatment for monotherapy. These deciding factors for treatment are highlighted in
Figure 1. Beyond the treatment choice, there is importance to implementing treatment early
after the onset of anxiety. In general, there are more favorable outcomes for those with mild to
moderate anxiety if they receive treatment early, regardless of the treatment choice. Thus,
treatment should be offered for all patients with a diagnosis of anxiety, no matter their
severity.
Implications for Future Practice
Clinical Pearls
Pediatric anxiety is highly prevalent yet significantly under-diagnosed and most often
remains untreated. Diagnosing anxiety is hindered by the various and vague clinical
presentations. It is also often underreported by family due to failure to recognize, concern of
stigma, or writing it off as personality characteristic or shy disposition. Providers should be
attentive to common presentations including various somatic complaints, shy disposition,
avoidance of eye contact, history of school avoidance, frequent nurse visits, or children of
anxious parents. If suspected, pediatric patients should be screened more carefully for an
anxiety diagnosis. A quick two question method of screening may include: “Do you find yourself
avoiding social situations or activities?” and “Are you fearful or embarrassed in social settings?”
If answering yes to either question, then a more formal screening of either PARS or SCARED
would be appropriate to more thoroughly screen for anxiety (Burns & Thiessen, 2014). If
anxiety is present, there are very effective treatment options with high response and remission
rates, but the key is to identify anxiety early for the best long-term outcome. If not dealt with,
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chronic and persistent anxiety is considered a gateway to comorbidities in adulthood (Ege &
Reinholdt-Dunne, 2016). Nonetheless, with early detection, treatment has success rates as high
as 80% (Beidas et al., 2014). Those treated for childhood anxiety also have fewer anxietyrelated dysfunctions and disorders as an adult (Burns & Thiessen, 2014). The severity of anxiety
at the time of diagnosis has some implication to the treatment recommendations. Of the
treatment options available, the combination of CBT and an SSRI is the superior treatment
approach across all severity levels. Those who receive combination therapy can consistently
expect sustained and maintained reduction in their anxiety (Walkup et al., 2008). When both
options cannot be utilized together, CBT has been shown to be superior to medication alone
with its lasting effects and benefits (James et al., 2018). However, providers should remember
that children with anxious parents benefit more from medication (Gonzalez et al., 2015).
Additionally, multiple studies not only show high rates of response for CBT but high rates of
remission and continued benefit for years after discontinuing treatment. An algorithm that
highlights these clinical pearls and considerations has been developed based off this literature
review to further guide providers in identifying and managing childhood anxiety, see Figure 1.
One final clinical pearl is for providers to have a positive perception about treatment as this
leads to better outcomes. In general, if patients and families have a positive perception about
the treatment, they are more likely to have positive outcomes. The same is true for the
opposite, since if they have a negative perception about treatment, they likely will have
unfavorable outcomes. This emphasizes the importance of meeting family where they are.
Providers need to identify modifications that can be done to overcome barriers of treatment
and evaluate how to best address any concerns regarding treatment to yield the best outcome.
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Referring to Cognitive Behavioral Therapy
Cognitive behavioral therapy can be implemented as early as six years of age. The
important component is that they have the cognitive capability to utilize the CBT techniques.
Some studies have reported effectiveness in children younger than six years of age, but this is
the exception and decision should be made on a case by case basis for those younger than six
(James et al., 2018). There are multiple settings where CBT has been shown to be equally
effective in; the one caveat being that other than face-to-face, these other treatment options
are not yet widely accessible. Only recently has literature explored other practical solutions for
implementing CBT besides face-to-face. Alternative modalities should be the future but
currently their availability is limited. While awaiting these other modalities for CBT, working
with families to overcome any barriers to receiving face-to-face therapy is optimal. It is worth
noting that for the treatment of anxiety, CBT usually takes 9-20 sessions (James et al., 2018).
The duration of CBT underlines the likely temporary need for treatment. This understanding
may make it more realistic and feasible for families. As for the cost of CBT, it may range from
$100-200 depending on the therapist. Of note, the cost of CBT has been found to be lower than
treatment as usual with a statistically significant difference after the first year of CBT versus
pharmacotherapy (Dickerson et al., 2018). The other modalities that have been recently studied
have likewise shown cost savings, particularly with therapist-guided internet delivered CBT
(ICBT). ICBT includes minimal therapist assistance and has proven to be effective with
substantial cost savings (Lenhard et al., 2017). ICBT allows for in home treatments at the parent
or child’s convenience and eliminates many barriers to receiving CBT. Researchers and
government agencies should focus their efforts on effectiveness and coverage of these
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modalities since sustained anxiety has a long-lasting impact and leads to strained personal and
national healthcare budgets (Lenhard et al., 2017). While awaiting these efforts, the
recommended resources that have proven helpful for families include Timid to Tiger: A
Treatment Manual for Parenting the Anxious Child (Norman et al., 2015) and The Coping Cat
programs (Salloum et al., 2016). The Timid to Tiger manual is available online at no cost and can
be utilized as a tool for parents of anxious children. The Coping Cat programs include the Camp
Cope-A-Lot and Child Anxiety Tales and have the advantage of being completely computer
driven with both a parent and child program available. Camp Cope-A-Lot is computer-delivered
CBT, with therapist assistance, for children. The Child Anxiety Tales is computer-based parent
training. The Coping Cat programs are available in 4-month or 12-month subscriptions, costing
$99 or $125 respectively. The Coping Cat is also an excellent resource for providers. These three
options, along with face-to-face CBT, are the current favored treatment approaches for CBT
(James et al., 2018).
Recommendations for Research
There are many areas in need of further research for childhood anxiety but since it has
been well established that CBT is effective and even superior in some cases, efforts of research
should be focused on how to make CBT more accessible. Dissemination of an effective
technique for CBT is an important research field (De Souza et al., 2013). Small studies have
been done looking at the effectiveness of CBT in a variety of formats and settings. Larger
studies evaluating these modalities should be done to confirm their effectiveness and further
the plans for dissemination. ICBT is available and remains promising but few are utilizing it.
Another potential promising setting for CBT is in schools. Those who work in schools are in an
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ideal position to help recognize social anxiety (Burns & Thiessen, 2014). Children often present
to the nurse’s office with varying complaints making school a likely place for the first signs of
anxiety. Trials should be done for CBT delivered within schools, with similar style to how
children receive speech therapy at school. CBT delivered at school would be ideal and help with
overcoming common barriers to treatment (Chiu et al., 2013). Thinking to the future, more
long-term studies should be conducted looking at relapse rates of anxiety when treated with
CBT versus pharmacotherapy. If CBT has more of a curative effect by delivering behavioral
modifications as opposed to a short-term effect of pharmacotherapy, this may drastically
change future recommendations once CBT is more easily accessible.
Recommendations for Education
Evidence-based treatment is often slow to filter from research settings into the realworld. There is another gap between educating about first line treatment options and the
reality of how to obtain said treatment options. Academic centers should not only focus efforts
on what are the first line treatment options, but how, as future providers, these options will be
obtained. CBT is widely underutilized due to the lack of provider knowledge surrounding how to
obtain this treatment approach.
Recommendations for Policy
Recommendations for policy largely surround the need for coverage of the cost for
nonpharmacological interventions. One barrier to receiving CBT is the cost, even though in the
long run CBT has substantial cost savings (Lenhard et al., 2017). It is imperative to address
policy change and coverage at a government level because childhood anxiety impacts the
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whole family function and can lead to anxiety and psychological conditions in adulthood.
Moreover, the cycle could continue, and contribute to their future children’s potential for
anxiety (Nordh et al., 2017). Anxiety runs a chronic, cyclical course if untreated, in turn
negatively impacting the economy. Nordh et al. (2017) evaluated the impact of pretreatment
anxiety on family functioning. They found that pretreatment, 27% of parents were staying
home frequently due to their child’s anxiety. Childhood anxiety does not solely impact that
child and their future, but rather the whole family and community around them. This in turn
has a huge impact on the economy as a whole. It would be wise for policy change to occur to
facilitate treatment of childhood anxiety.
Conclusion
Anxiety is incredibly prevalent among the pediatric population and is one disease that
has been commonly overlooked and untreated. Most everyone experiences anxiety symptoms
at some point in their lives, which may be in part why it is underdiagnosed. However, these
normal fleeting anxiety symptoms are different than the dysfunctional emotional response
seen in anxiety diagnoses (Ege & Reinholdt-Dunne, 2016). Considering anxiety is a dysfunctional
emotional response, CBT is an obvious effective treatment for it is based on the concept that
fear and anxiety are learned behaviors that can be unlearned (James et al., 2018). CBT differs
from pharmacotherapy in that it is addressing the underlying maladaptive psychological
thought process and is providing lifelong coping and adaptive skills. It has been shown to be
more effective than pharmacology alone and is considered a first line treatment in childhood
anxiety but is not being utilized as such. This must change. Ideally, prevention of childhood
anxiety would be best. Providers should be encouraging nurturing parent-child relationships as
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the early childhood years are the most critical for mental wellness (Burns et al., 2017).
Providers should often inquire about mental health as many families are reluctant to share
concerns spontaneously. Anticipatory guidance should not be overlooked as it becomes the
building blocks for mental health in children. When the opportunity for primary prevention has
been missed, providers must then rely on early detection and intervention. Mild anxiety
followed by early intervention has the most likelihood of success and remission. If providers do
not intervene, sustained anxiety will likely lead to significant impairment and become a strong
risk factor for severe psychopathology in adulthood. The negative outcomes of untreated
anxiety are not what providers intend for their pediatric patients’ futures. It is time for due
diligence in tackling childhood anxiety and promoting pediatric mental health.
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Appendix
Figure 1
Pediatric Anxiety Treatment Algorithm

39
Tables 1
Database Search Description
Database
Cochrane

Restrictors/Expanders Dates Included in
Added to Search
Database
Full Text, apply
2009-2020
related words, search
within text

CENTRAL

Abstract available

2009-2020

MEDLINE

Peer Reviewed, Full
text, age 0-18
(specified)

2009-2020

CINAHL

Full Text, Peer
Reviewed

2009-2020

PsycINFO

Full Text, Peer
Reviewed, Childhood
(0-12), Adolescence
(13-17)

2009-2020

(MSU, 2019)

General Subjects
Covered in Database
Contains articles and
protocols focusing
on the effects of
healthcare and
providing evidencebased medicine data
Controlled trials
providing unbiased
source of data and
systemic review.
Covers a variety of
medical topics in
various domains
including medicine,
nursing as well as
dentistry and
veterinary.
Providers literature
on nursing and allied
health.
Provides literature
about the disciplines
related to
psychology including;
psychiatry,
education, medicine
nursing and more.
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Table 2
Data Abstraction Process: Hit Results by Database
Key Words
“Mindfulness”

“Mindfulness” AND
“Anxiety”
“CBT”
“CBT” AND “Anxiety
“Cognitive
Behavioral Therapy”
AND “Anxiety”
“Mindfulness” AND
“Anxiety” AND
“Pediatrics”
“CBT” AND
“Anxiety” AND
“Pediatrics”
“Cognitive
Behavioral Therapy”
AND “Anxiety” AND
“Pediatrics”
“Treatment” AND
“Pediatric” AND
“Anxiety” AND
“Mindfulness”
“Treatment” AND
“Pediatric” AND
“Anxiety” AND
“Cognitive
Behavioral Therapy”
“Outcome” AND
“Pediatric” AND
“Anxiety” AND
“Mindfulness”
“Outcome” AND
“Pediatric” AND
“Anxiety” AND
“Cognitive
Behavioral Therapy”

Cochrane
127/
8 (without
expanders)
117

CENTRAL
3,644

MEDLINE
1,443

CINAHL
2,019

PsycINFO
826

1,343

395

X

X

236
205
67

5,416
2,344
3,089

1,250
496
781

X
X
X

X
X
X

16

18

7

14

37

104

25

149

13

131

19/
2 (for age group
0-18)
30/
4 (for age group
0-18)
34/
8 (for age group
0-18)

20

151

27

8

0

3*

16

122

152

7

19*

264

27

13

1

5

11

123

133

7

11*

165
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“Treatment” AND
“Pediatric” AND
“Anxiety” AND
“Pharmacological”
“Pediatric anxiety”
AND “Treatment”
AND “Evidence
Based”
“Pediatric anxiety”
AND “Treatment”
AND “Evidence
Based” AND
“Mindfulness or
Cognitive Behavioral
Therapy”
“Assessment and
Treatment” AND
“Pediatric or Child”
AND “Anxiety
Disorder”
Correlating
Strategy:
“children OR child
OR pediatric OR
adolescent” AND
“CBT OR cognitive
behavioral therapy
OR mindfulness”
AND
“pharmacological
OR treatment OR
management” AND
“anxiety OR anxiety
disorder”
Bibliography Review

135

40

0

2*

55

1*

4*

14

27

122

0

4*

2*

4*

9*

166

7

14*

9*

54

4

X

344

208/
619
44*
(with
exclusion
criteria
applied
to
search)

2*

Note
* BOLD= articles reviewed for inclusion and exclusion criteria.
X= not searched in database
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Table 3
Characteristics of Literature Included and Excluded
Reference
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(2014). Eight years later: Outcomes of CBT-treated versus
untreated anxious children. Brain and Behavior, 4(5), 765774. https://doi.org/10.1002/brb3.274
Beidas, R., S., Lindhiem, O., Brodman, D., M., Swan, A., Carper
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